Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma
Authors:
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 31 (12) , 1882-1890
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cancer Drugs Approved Based on Biomarkers and Not Tumor Type—FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid CancersJAMA Oncology, 2018
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 studyThe Lancet Oncology, 2017
- Lynch or Not Lynch? Is that Always a Question?2012
- A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndromeHereditary Cancer in Clinical Practice, 2010
- Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based studyBritish Journal of Cancer, 2010
- Prediction of Lynch Syndrome in Consecutive Patients With Colorectal CancerJNCI: Journal of the National Cancer Institute, 2009
- Immunohistochemistry versus Microsatellite Instability Testing For Screening Colorectal Cancer Patients at Risk For Hereditary Nonpolyposis Colorectal Cancer SyndromeThe Journal of Molecular Diagnostics, 2008
- Screening for the Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)New England Journal of Medicine, 2005
- Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesisNature, 1993
- Microsatellite Instability in Cancer of the Proximal ColonScience, 1993